Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009

International Journal of Antimicrobial Agents

Volumn 38, Issue 4, 2011, Pages 291-295

  Master, Ronald N ^a   Clark, Richard B ^a   Karlowsky, James A ^b   Ramirez, Julio ^c   Bordon, Jose M ^d  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c University of Louisville School of Medicine   (United States)

^d Providence Hospital Washington DC   (United States)

Author keywords

Antimicrobial resistance; Antimicrobial susceptibility; Cross resistance; Multidrug resistance; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIUM ISOLATE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CROSS RESISTANCE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW;

EID: 80052265813     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.04.022     Document Type: Article

References (14)

1. S.C. Brewer, R.G. Wunderlink, C.B. Jones, and K.V. Leeper Ventilator-associated pneumonia due to Pseudomonas aeruginosa Chest 109 1996 1019 1029 (Pubitemid 26113647)
2. A.M. Nicasio, J.L. Kuti, and D.P. Nicolau The current state of multidrug-resistant Gram-negative bacilli in North America Pharmacotherapy 28 2008 235 249
3. J. Van Eldere Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections J Antimicrob Chemother 51 2003 347 352 (Pubitemid 36231155)
4. M.D. Obritsch, D.N. Fish, R. MacLaren, and R. Jung National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002 Antimicrob Agents Chemother 48 2004 4606 4610 (Pubitemid 39577660)
5. J.A. Karlowsky, M.E. Jones, C. Thornsberry, A.T. Evangelista, Y.C. Yee, and D.S. Sahm Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 Tracking Resistance in the United States Today surveillance studies Clin Infect Dis 40 Suppl. 2 2005 S89 S98
6. M.D. Obritsch, D.N. Fish, R. MacLaren, and R. Jung Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options Pharmacotherapy 25 2005 1353 1364 (Pubitemid 41407633)
7. G.B. Pier, and R. Ramphal Pseudomonas aeruginosa G.L. Mandell, J.E. Bennett, R. Dolin, Mandell, Douglas, and Bennett's principles and practice of infectious diseases 6th ed. 2005 Churchill Livingstone Philadelphia, PA 2587 2615
8. Clinical and Laboratory Standards Institute. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline. 3rd ed. Document M39-A3. Wayne, PA: CLSI; 2009.
9. P.R. Rhomberg, and R.N. Jones Summary trends for the Meropenem Yearly Susceptibility Test Information Collection program: a 10-year experience in the United States (1999-2008) Diagn Microbiol Infect Dis 65 2009 414 426
10. D.F. Sahm, M.K. Marsilio, and G. Piazza Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database - USA Clin Infect Dis 29 1999 259 263 (Pubitemid 29380180)
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
12. J.A. Karlowsky, D.C. Draghi, M.E. Jones, C. Thornsberry, I.R. Friedland, and D.S. Sahm Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States Antimicrob Agents Chemother 47 2003 1681 1688 (Pubitemid 36548554)
13. V.H. Tam, E.A. Gamez, J.S. Weston, L.N. Gerard, M.T. LaRocco, and J.P. Caeiro Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint Clin Infect Dis 46 2008 862 867 (Pubitemid 351417187)
14. M. Paul, I. Benuri-Silbiger, K. Soares-Weiser, and L. Leibovici β Lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomized trials BMJ 328 2004 668 681